New Research on Gut Health and Dog Seizures: Understanding the Gut–Brain Connection in Dogs with Canine Epilepsy

For many years, epilepsy in dogs was thought of as a condition affecting only the brain. But new scientific research is changing the way we view the gut–brain connection in dogs with canine epilepsy. Studies are now showing that the gut, and the vast community of bacteria and chemicals living within it may also play a surprisingly important role in seizure activity, inflammation, and even how well dogs respond to medication.

This emerging area of science is known as the gut–brain axis, and it has become one of the most exciting frontiers in understanding canine epilepsy. The latest peer-reviewed study (included in the references below) highlights measurable differences in the gut microbiome and gut-derived metabolites of healthy dogs, dogs with well-controlled epilepsy, and dogs with drug-resistant epilepsy.

This article breaks down the findings in a friendly, accessible way so dog owners can understand what this research means — and why it brings hope for future interventions.

If you’re new to epilepsy triggers, you may also find dog seizure triggers helpful.

Why the Gut Matters in Dogs With Epilepsy

The gut and the brain are connected through nerves, hormones, immune cells, and microbial chemicals. This communication system — the gut–brain axis — helps regulate:

• inflammation

• stress and mood

• neurotransmitters

• metabolic balance

• immune responses

  
  

In humans, altered gut bacteria have been linked to epilepsy, anxiety, depression, and neurological disorders. Similar patterns are now being discovered in dogs.

Many owners also notice that seizures sometimes coincide with stress, digestive problems, or dietary changes, which reflects how tightly the gut and brain are linked.

To explore this further, you may find how to identify gut issues in epileptic dogs useful.

What the New Study Found: Key Scientific Insights

The research examined stool samples from:

• healthy dogs

• dogs with well-controlled idiopathic epilepsy

• dogs with drug-resistant idiopathic epilepsy

  
  

Scientists analysed both microbial composition (which bacteria are present) and metabolites (the chemical outputs of digestion and microbial activity). The results showed striking differences — especially in dogs whose seizures were not well controlled with medication.

Below are the key findings explained simply.

1. Epileptic Dogs Have Different Gut Chemical Profiles

The metabolomic analysis revealed differences in several important pathways, including:

✔ Serotonin-related metabolites

✔ Tryptophan breakdown pathways

✔ Short-chain fatty acids (SCFAs)

✔ Bile acid–related compounds

These chemicals influence:

• inflammation

• mood and stress

• sleep–wake cycles

• digestion

• neuronal excitability (how easily the brain triggers a seizure)

  
  

When these pathways are disrupted, the brain may become more sensitive. This may help explain why some dogs are more reactive to food triggers, explored in foods that cause seizures in dogs.

2. Histamine Was Significantly Higher in Drug-Resistant Epilepsy

One of the most important findings was increased histamine-related metabolites in dogs with drug-resistant epilepsy (DRE).

Histamine is involved in:

• inflammation

• immune responses

• wakefulness

• stress signalling

• neurological activity

  
  

Higher histamine may be linked to:

• increased inflammation

• disrupted sleep (a known trigger)

• heightened neuronal firing

  
  

This provides a possible biological explanation for why some dogs remain difficult to stabilise despite medication.

For more on inflammatory triggers, see toxins in dog food and epilepsy.

3. Serotonin Pathways Were Also Altered

Serotonin is produced largely in the gut, not the brain. This study found disturbances in tryptophan metabolism, the biochemical pathway used to make serotonin.

Because serotonin influences:

• stress behaviour

• gut movement

• sleep

• neurological stability

  
  

…these differences may help explain why stress and gut health affect seizure activity.

For a practical explanation of stress triggers, you can read can stress cause seizures in dogs?.

4. Microbiome Differences Were Present — but Subtle

The differences in bacterial species were less dramatic than the metabolite changes, but still meaningful. Dogs with epilepsy showed:

• slightly reduced beneficial bacteria

• increased inflammatory‐linked bacteria

• differences in bacteria linked to bile acids and neurotransmitter pathways

  
  

This supports the idea that the microbiome influences the neurological system indirectly through chemical pathways, rather than only through “good vs bad” bacteria.

5. Dogs With Drug-Resistant Epilepsy Had the Most Significant Changes

The most altered gut chemistry and microbial signatures belonged to dogs whose seizures were poorly controlled with medication.

This included:

• the highest histamine levels

• the greatest inflammation-related pathway disruption

• clear disturbances in tryptophan/serotonin metabolism

• altered SCFA-associated bacteria

  
  

This suggests gut health may be a factor in medication resistance, a major discovery in canine epilepsy research.

Positive Signs: How the Gut Microbiome Might Be Supported in Future

Although this study highlights challenges, it also opens up hopeful pathways. Several other studies show the gut microbiome in dogs is highly modifiable, meaning future interventions may eventually help support seizure control.

Here are the most promising areas of emerging research.

1. Diet Has Been Shown to Shift the Microbiome in Epileptic Dogs

A previous study found that a ketogenic, MCT-enriched diet led to measurable changes in the gut bacteria of epileptic dogs, including reductions in microbial groups associated with inflammation. You can learn more about the ketogenic diet here.

These changes were particularly noticeable in dogs whose seizures were well controlled, hinting at a link between diet, microbiome, and seizure stability.

For more on dietary principles, see the best diet for dogs with epilepsy.

2. Probiotics Show Early but Promising Results

A small pilot study using canine-derived probiotic strains found that:

• some dogs experienced fewer seizure days

• the microbiome became more diverse

• inflammatory markers improved

  
  

This is very early evidence , but it is the first research in dogs suggesting probiotics might influence seizure patterns.

Learn more in probiotics and the gut–brain axis.

3. Short-Chain Fatty Acids (SCFAs) Are a Potential Target

Dogs with epilepsy often have fewer bacteria that produce SCFAs — beneficial compounds that support:

• gut lining integrity

• immune regulation

• anti-inflammatory pathways

• neurological balance

  
  

Future interventions may focus on restoring SCFA production through diet or targeted microbial support.

A Note on Early-Stage Research

Because this is a new scientific field, it’s important to understand the limitations:

• We do not yet know which gut changes cause seizures

• We do not know whether improving the microbiome improves epilepsy

• We do not have standardised or evidence-based protocols for microbiome modulation

• More research is needed to turn these findings into practical recommendations

  
  

However, the direction of research is clear:

The gut–brain axis is an exciting, rapidly growing area that may eventually contribute to better management of canine epilepsy.

Conclusion: Gut–Brain Connection in Dogs with Epilepsy

This new research shows that dogs with epilepsy, especially drug-resistant cases, have measurable differences in their gut microbiome and gut-derived chemicals. These findings don’t offer a cure, but they do offer hope.

By understanding how the gut, immune system and brain interact, scientists are beginning to uncover why some dogs respond differently to treatment, why seizures fluctuate, and how future interventions may support better stability.

Epilepsy is complex, but the gut–brain connection gives us a broader, more holistic understanding, and a meaningful direction for future study.

FAQs

Can improving my dog’s diet really help with epilepsy?

Yes, research shows that diet can influence seizure patterns in some dogs. In particular, ketogenic and MCT-enriched diets have been shown to reduce seizure frequency and support more stable brain activity in several studies. While diet is not a cure, the evidence is strong enough that nutrition is now considered an important part of modern epilepsy management. Read more about the ketogenic diet here.

Has the ketogenic diet been scientifically proven to help dogs with seizures?

Yes. Multiple peer-reviewed studies (including randomised controlled trials) show that ketogenic diets and MCT oil can reduce seizure frequency in dogs with idiopathic epilepsy. These diets appear to influence both energy metabolism and the gut microbiome, two areas now known to interact with brain activity. The ketogenic approach is widely used in human medicine and is becoming increasingly recognised in veterinary neurology.

Can supporting gut health really make a difference for dogs with epilepsy?

Early research suggests it may. New studies show that dogs with epilepsy often have distinct gut microbiome and metabolite profiles, especially those with drug-resistant seizures. While more work is needed, supporting gut health is a promising area of interest because the gut–brain axis influences inflammation, stress, and neurological balance.

Are probiotics helpful for seizure-prone dogs?

They might be. A small but exciting pilot study using canine-derived probiotics found improvements in microbiome diversity and a reduction in seizure days for some dogs. This doesn’t make probiotics a treatment, but it shows real potential — and scientists are actively researching which strains may be most beneficial.

Is stress really connected to dog seizures?

Yes. Stress affects sleep, inflammation and gut health — all of which can influence seizure thresholds. Many owners notice patterns around stressful events, and emerging research on the gut–brain axis helps explain why. Understanding stress triggers can be very helpful; you can learn more in our guide to stress and seizures in dogs.

Does this research mean epilepsy is more than just a brain disorder?

It points in that direction. Scientists are increasingly viewing epilepsy as a condition involving the whole body, including gut health, the immune system, inflammation, diet and stress responses. This broader perspective offers more avenues for supporting dogs beyond medication alone.

Are there safe, science-supported ways to complement my dog’s medical treatment?

Yes — several supportive approaches have early evidence behind them, including:

• ketogenic/MCT-enriched diets

• gut health support

• probiotic research

• inflammation-aware nutrition

• better stress/sleep routines

These do not replace medication but may work alongside veterinary care to support overall stability.

Is more research coming?

Absolutely. Epilepsy research is expanding rapidly, especially in the areas of the microbiome, inflammation, nutrition, stress biology and metabolic health. The newest findings are the most hopeful we’ve seen, and they point toward a future where seizure management becomes more personalised and holistic.

References

• Bishop, S., Petrie, M., Paz, I., Safi, F., Martlé, V., Williams, G., Gommeren, K., Biskup, S., Van Ham, L., Volk, H.A., Bhatti, S. & Craig, L., 2025. Gut and faecal metabolome and microbiome alterations in drug-resistant idiopathic epileptic dogs. Scientific Reports, 15, 9197. Available at: https://doi.org/10.1038/s41598-025-09919-7.

• World Health Organization. Epilepsy: A Public Health Imperative. WHO Press (2019).

• Bhatti, S. F., De Risio, L., Muñana, K., O’Neill, D. G., Penderis, J., Stein, V. M., Tipold, A., Volk, H. A. & Walker, M. C. International veterinary epilepsy task force consensus report on epilepsy definition, classification and terminology in companion animals. BMC Vet Res 11, 1–12 (2015).

• Potschka, H., Fischer, A., Löscher, W., Patterson, E. E., Bhatti, S. F., Berendt, M., De Risio, L., Farquhar, R. G., Long, S., Lubas, G., Munana, K., Otomaru, H., Pakozdy, A., Penderis, J., Platt, S., Rupprecht, C. E., Steffen, F., Stengel, O., Tipold, A., Volk, H. A. & The International Veterinary Epilepsy Task Force. International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy. BMC Vet Res 11, 1–14 (2015).

• Berendt, M., Farquhar, R. G., Mandigers, P., Pakozdy, A., Bhatti, S. F., De Risio, L., Fischer, A., Long, S., Munana, K. R., Patterson, E. E., Platt, S. R., Podell, M., Potschka, H., Penderis, J., Steffen, F., Tipold, A., Volk, H. A. & International Veterinary Epilepsy Task Force. International Veterinary Epilepsy Task Force Consensus Report on epilepsy diagnosis in dogs. BMC Vet Res 11, 1–16 (2015).

• Hülsmeyer, V.-I., Fischer, A., Mandigers, P. J. J., De Risio, L., Berendt, M., Rusbridge, C., Bhatti, S. F., Pakozdy, A., Patterson, E. E., Platt, S., Tipold, A., Volk, H. A. & IVETF. International Veterinary Epilepsy Task Force’s current understanding of idiopathic epilepsy of genetic or suspected genetic origin in purebred dogs. BMC Vet Res 11, 1–14 (2015).

• Barnard, S., Aprea, F., Algarott, A., Cero, C., & others. Clinical presentation and breed predisposition for idiopathic epilepsy in dogs. BMC Vet Res 18, 298 (2022).

• Muñana, K. R. Management of refractory epilepsy. Top Companion Anim Med 28, 67–71 (2013).

• Berendt, M., & Gram, L. Epilepsy and seizure classification in dogs. J Vet Intern Med 11, 77–82 (1997).

• De Risio, L. & Platt, S. Canine epilepsy: Prediction of drug resistance. Vet Rec 182, 197–199 (2018).

• Berendt, M. & Gram, L. Epilepsy in dogs: Aetiology, classification, clinical diagnosis and prognosis. J Small Anim Pract 40, 19–27 (1999).

• Jokinen, T. S., Pääkkönen, T., Gröhn, H., & others. Seizure disorders in dogs: a retrospective study of 243 cases. J Am Anim Hosp Assoc 43, 244–250 (2007).

• Löscher, W. Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol Sci 23, 113–118 (2002).

• Kearsley-Fleet, L., O’Neill, D. G., Volk, H. A., Church, D. B. & Brodbelt, D. C. Prevalence and risk factors for canine epilepsy of 2,235 dog cases in primary care in the UK. Vet J 238, 27–33 (2018).

• Granger, P., Biton, V., Faure, C., Viau, C., Depaulis, A. & et al. The effects of levetiracetam on epilepsy models. Epilepsy Res 54, 161–174 (2003).

• Whalley, B. J., Stephens, G. J. & Wilcox, K. S. Therapeutic potential of cannabinoids in epilepsy. Neurosci Lett 667, 32–42 (2018).

• Reisinger, S., Koller, F. L., Muñana, K., & others. Gut microbiome in canine idiopathic epilepsy — effects of disease and treatment. Animals 11, 3121 (2021).

• Pilla, R., Li, Q., Melgarejo, T., & others. Fecal microbiota transplantation in dogs with idiopathic epilepsy: results of a pilot study. Front Vet Sci 8, 656 (2021).

• Barko, P. C., McMichael, M. A., Swanson, K. S. & Fahey, G. C. The gastrointestinal microbiome: a review. J Anim Sci 96, 1250–1265 (2018).

• Oliphant, K. & Allen-Vercoe, E. Microbial diversity in the human gut and its impact on health. Nat Rev Gastroenterol Hepatol 16, 69–81 (2019).

• Pandit, R. J., Hinsu, A. T., Patel, S. H. & others. Exploring the gut microbiome and metabolome in dogs with epilepsy. Metabolites 12, 722 (2022).

• Sokol, H., Leducq, V., Aschard, H. & others. Fusobacterium nucleatum and inflammation. Gut 66, 688–699 (2017).

• Ma, Q., Xing, C., Long, W., Wang, H.-Y. & Liu, Q. Role of histamine in immune responses and inflammation. Eur J Pharmacol 882, 173304 (2020).

• Phillips, C., Peryer, G., et al. Histamine and neurological signalling. Neurochem Int 130, 104–110 (2019).

• The human metabolome database (HMDB). Histamine Metabolism. www.hmdb.ca (accessed 2024).

• ChemSpider. Histamine–related metabolites. Royal Society of Chemistry (accessed 2024).